Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • laser interstitial thermal therapy

    - PMLiVE

    UK and US agree on landmark pharma pricing tariff deal

    US tariffs on UK-produced pharmaceuticals will remain at zero for three years

    - PMLiVE

    UCB’s Fintepla shows positives results for Lennox-Gastaut syndrome

    The study demonstrated a sustained reduction in seizures for patients

    - PMLiVE

    ViiV Healthcare receives NICE recommendation for HIV prevention therapy

    The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

    - PMLiVE

    New National Commission launched to strengthen AI regulation

    The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance

    Epilepsy meds app silver award at PMi Awards

    Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App

    Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.

    Genetic Digital

    - PMLiVE

    PhotoPharmics’ new advisory board to guide launch of FDA Breakthrough device for Parkinson’s

    The US-based company develops light-based therapies for neurodegenerative conditions

    - PMLiVE

    NHS programme to give head and neck cancer patients fast-track access to mRNA vaccine

    More than 11,000 people are diagnosed with head and neck cancers every year in England

    Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds.

    Genetic Digital Shortlisted for PM Society Digital Award for Epilepsy Meds App

    Genetic Digital has been shortlisted for a PM Society Digital Award for Epilepsy Meds, a mobile-first app that helps healthcare professionals make safer, patient-specific prescribing decisions in epilepsy care. The...

    Genetic Digital

    - PMLiVE

    NICE recommends BeOne’s Brukinsa to treat mantle cell lymphoma on NHS

    Approximately 600 people are affected by the form of non-Hodgkin lymphoma every year in the UK

    - PMLiVE

    UK government publishes 10 Year Health Plan for England to ‘reinvent’ NHS

    The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

    - PMLiVE

    UCB shares promising results for fenfluramine in ultra-rare form of epilepsy

    CDKL5 deficiency disorder occurs in approximately one in 40,000 to 60,000 live births

    - PMLiVE

    NHS patients to access Theramex’s endometriosis pill following NICE recommendation

    The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links